AUTOMA+ 2025 invites over 300 delegates from pharmaceutical, biotech, CMO, CDMO, CRO, equipment manufacturing and service provider companies. This number embraces both top executives and technical specialists, as well as experts in digital transformation, IT, data management, R&D, manufacturing, plant operations, marketing and more.
Louise Lind Skov, Head of Content Digitalisation at Novo Nordisk, shared her expression on opportunities for professional networking at the Congress:
“I think, AUTOMA+ is well-organised because it gives a possibility of networking with a lot of other people in the pharma and biotech industries that are looking for the digital transformation. It gives a broad spectrum of what the pharmaceutical industry really is, and I’ve learned a lot by participating”.
This year, the company is going to be represented by the speaker Lars Westergaard Luxhoej, Senior Director, within the roundtable dedicated to the labelling and packaging.
The business programme of the Congress combines deep dives into the digital transformation of core pharmaceutical processes – R&D, manufacturing, packaging, labelling, and supply chain – with cross-cutting priorities such as sustainability, patient experience, AI, data management, key industry challenges and digital strategies.
One of the main highlight of AUTOMA+ 2025 is the executive opening panel, where the management of the leading companies discuss digital technologies for upgrading pharma operations. Delegates have the opportunity to gain insights from global pharma major Merck KGaA Darmstadt, regional leader Bayer Austria Ges.m.b.H. and innovative tech-driven companies such as Albocensa, anic GmbH and SCARLETRED Holding GmbH.
The company Innowise supports the Congress as the Principal Sponsor for the second time. During the interview at AUTOMA+ 2024, Vitaly Levashov, Leading Product Consultancy at Innowise, mentioned that the company met several potential partners and those interactions sparked numerous discussions about the future collaboration opportunities. He also highlighted the value of the B2B meetings:
“We strongly believe that B2B meetings organised for us at the Congress were highly beneficial, allowing us to connect directly with end users and gain insights related to their needs and challenges. These meetings provided a structured environment to discuss potential collaborations and understand how our solutions can meet their requirements”.
Moreover, the agenda includes a special celebration of the 5th anniversary, featuring a celebration gala dinner and grand lottery, gathering newcomers and long-term participants.
AUTOMA + 2025 is set to foster new business connections and drive the effective digital transformation of the pharmaceutical industry, bringing together Takeda, Accord Healthcare, Sandoz, Novartis, Bayer AG, Roche Diagnostics, Novo Nordisk, GSK, Grünenthal, ESTEVE and others.
Be a part of the anniversary: https://sh.bgs.group/2md
